Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · IEX Real-Time Price · USD
68.84
-0.88 (-1.26%)
May 20, 2024, 3:47 PM EDT - Market open
Utah Medical Products Market Cap
Utah Medical Products has a market cap or net worth of $243.07 million as of May 20, 2024. Its market cap has decreased by -26.83% in one year.
Market Cap
243.07M
Enterprise Value
152.48M
1-Year Change
-26.83%
Ranking
Category
Stock Price
$68.84
Market Cap Chart
Since March 8, 1999, Utah Medical Products's market cap has increased from $49.30M to $243.07M, an increase of 393.05%. That is a compound annual growth rate of 6.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 246.00M | -1.05% |
May 16, 2024 | 248.60M | 1.76% |
May 15, 2024 | 244.30M | 1.12% |
May 14, 2024 | 241.60M | - |
May 13, 2024 | 241.60M | -0.37% |
May 10, 2024 | 242.50M | -2.73% |
May 9, 2024 | 249.30M | 0.69% |
May 8, 2024 | 247.60M | -0.68% |
May 7, 2024 | 249.30M | 0.12% |
May 6, 2024 | 249.00M | 2.13% |
May 3, 2024 | 243.80M | 0.95% |
May 2, 2024 | 241.50M | -0.86% |
May 1, 2024 | 243.60M | 2.53% |
Apr 30, 2024 | 237.60M | -0.17% |
Apr 29, 2024 | 238.00M | 0.59% |
Apr 26, 2024 | 236.60M | -0.55% |
Apr 25, 2024 | 237.90M | -1.29% |
Apr 24, 2024 | 241.00M | -0.62% |
Apr 23, 2024 | 242.50M | -0.82% |
Apr 22, 2024 | 244.50M | -0.65% |
Apr 19, 2024 | 246.10M | 1.99% |
Apr 18, 2024 | 241.30M | -0.58% |
Apr 17, 2024 | 242.70M | -0.74% |
Apr 16, 2024 | 244.50M | -0.33% |
Apr 15, 2024 | 245.30M | -0.45% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
EDAP TMS | 251.93M |
Century Therapeutics | 251.86M |
Design Therapeutics | 249.71M |
ChromaDex | 246.38M |
2seventy bio | 245.97M |
Pyxis Oncology | 243.80M |
uniQure | 243.72M |
Coherus BioSciences | 242.65M |